Crossmark

Innate Immune Receptors, Key Actors in Cardiovascular Diseases

Crossref DOI link: https://doi.org/10.1016/j.jacbts.2020.03.015

Published Print: 2020-07

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Jaén, Rafael I.

Val-Blasco, Almudena

Prieto, Patricia

Gil-Fernández, Marta

Smani, Tarik

López-Sendón, José Luis

Delgado, Carmen

Boscá, Lisardo

Fernández-Velasco, María
Funding

Funding for this research was provided by:

Instituto de Salud Carlos III (PI17/01344)

Comunidad de Madrid

Amgen

European Social Fund

Boehringer Ingelheim España

Pfizer

Centro de Investigación Biomédica en Red Enfermedades Cardiovasculares

Federación Española de Enfermedades Raras (RTC2017-6283)

Federación Española de Enfermedades Raras (S2017/BMD-3686)

Federación Española de Enfermedades Raras (SAF2017-82436R)

Bayer

Ministerio de Educación, Cultura y Deporte

Ministerio de Economía y Competitividad

Sanofi

Merck
License Information

Text and Data Mining valid from 2020-07-01

Text and Data Mining valid from 2020-07-01

Version of Record valid from 2020-04-09
More Information

This article is maintained by: Elsevier

Article Title: Innate Immune Receptors, Key Actors in Cardiovascular Diseases

Journal Title: JACC: Basic to Translational Science

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.jacbts.2020.03.015

Content Type: article

Copyright: © 2020 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.